Patient P-01852
Synthetic patientNBL-101 · Day 114 · 65–74 · F · baseline S02Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
7%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S02
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience+7
- Treatment adherence+6
- Inflammatory activity-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion13.9/100
worsening · +10.9 vs previous 14 d
Toxicity
Blood14.8/100
worsening · +1.0 vs previous 14 d
Sleep quality
Wearable19.3/100
worsening · -8.7 vs previous 14 d
Energy level
Daily log6.6/10
worsening · -0.4 vs previous 14 d
Stress level
Daily log3.4/10
worsening · +0.4 vs previous 14 d
Steps
Wearable10,947
worsening · -528 vs previous 14 d
Adherence
Companion98.2 %
stable · +0.3 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading drifting · 94 from the failing basin, 9 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- FUT2 non-secretorhidden · steering -10.6
- Histamine loadperturbation · steering -6.3
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
- Histamine loaddetractor · GI +3.5 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+3.5detractor · 95%
- Insoluble fibre-1.5no signal · 51%
- Simple carbohydrates+0.9no signal · 25%
- Dietary fat load+0.6no signal · 15%
- Alcohol+0.5no signal · 16%
- Spicy / capsaicin+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.0 h, below personal baseline
- Autonomic recovery ↓20
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.4 · butyrate capacity 61/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 41 ms
- Sleep
- 6.0 h
- Steps
- 10,042
- Resting HR
- 70 bpm
Daily log: GI score 14, nutritional resilience 74, adherence 98.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.